FDA Clears BioSphere Medical's Next Generation Sequitor(TM) Steerable Guidewire (Business Wire via Yahoo! Finance)
ROCKLAND, Mass.----June 9, 2006--BioSphere Medical, Inc. , a medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, today announced that the U.S.

Seizure Detection Algorithm: FDA Clearance sought (Scoop.co.nz)
BrainZ Instruments Limited (ASX:BZI) today announced it has lodged a submission with the United States Food and Drug Administration ( FDA ) for its computerassisted seizure detection algorithm1.

Millennium Files SNDA For VELCADE(R) (Bortezomib) For Injection In Treatment Of Relapsed Or Refractory Mantle Cell (Medical News Today)
MillenniumPharmaceuticals, Inc. (Nasdaq: MLNM) today announced the Company has filed a supplemental new drug application (sNDA) with the U.S. Food and DrugAdministration (FDA) for VELCADE in the treatment of relapsed or refractorymantle cell lymphoma (MCL), an aggressive subtype of non-Hodgkin's lymphoma(NHL) that is not curable. [click link for full article]